<?xml version="1.0" encoding="UTF-8"?>
<SAMPLE_SET xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <SAMPLE alias="WCM10_1_N_WES_Tumor" accession="SRS4330242">
    <IDENTIFIERS>
      <PRIMARY_ID>SRS4330242</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMN10254562</EXTERNAL_ID>
      <EXTERNAL_ID namespace="dbGaP" label="Sample name">1666-WCM10_1_N_WES_Tumor</EXTERNAL_ID>
      <EXTERNAL_ID namespace="phs001666" label="submitted sample id">WCM10_1_N_WES_Tumor</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Adenocarcinoma tumor DNA sample from Lymph node of a human male participant in the dbGaP study "Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer"</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_accession</TAG>
        <VALUE>phs001666</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitter handle</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study name</TAG>
        <VALUE>Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study design</TAG>
        <VALUE>Case Set</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository sample id</TAG>
        <VALUE>WCM10_1_N_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted sample id</TAG>
        <VALUE>WCM10_1_N_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted subject id</TAG>
        <VALUE>WCM10</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_sample_id</TAG>
        <VALUE>3312216</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_subject_id</TAG>
        <VALUE>2765720</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study disease</TAG>
        <VALUE>Adenocarcinoma</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>body site</TAG>
        <VALUE>Lymph node</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>histological type</TAG>
        <VALUE>Tissue : Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>analyte type</TAG>
        <VALUE>DNA</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>is tumor</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>subject is affected</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_code</TAG>
        <VALUE>1</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_short_name</TAG>
        <VALUE>HMB-PUB</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="WCM15_1_N_WES_Tumor" accession="SRS4330243">
    <IDENTIFIERS>
      <PRIMARY_ID>SRS4330243</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMN10254571</EXTERNAL_ID>
      <EXTERNAL_ID namespace="dbGaP" label="Sample name">1666-WCM15_1_N_WES_Tumor</EXTERNAL_ID>
      <EXTERNAL_ID namespace="phs001666" label="submitted sample id">WCM15_1_N_WES_Tumor</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Adenocarcinoma tumor DNA sample from Lymph node of a human male participant in the dbGaP study "Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer"</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_accession</TAG>
        <VALUE>phs001666</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitter handle</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study name</TAG>
        <VALUE>Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study design</TAG>
        <VALUE>Case Set</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository sample id</TAG>
        <VALUE>WCM15_1_N_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted sample id</TAG>
        <VALUE>WCM15_1_N_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted subject id</TAG>
        <VALUE>WCM15</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_sample_id</TAG>
        <VALUE>3312221</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_subject_id</TAG>
        <VALUE>2765721</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study disease</TAG>
        <VALUE>Adenocarcinoma</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>body site</TAG>
        <VALUE>Lymph node</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>histological type</TAG>
        <VALUE>Tissue : Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>analyte type</TAG>
        <VALUE>DNA</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>is tumor</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>subject is affected</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_code</TAG>
        <VALUE>1</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_short_name</TAG>
        <VALUE>HMB-PUB</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="WCM154_1_N_WES_Tumor" accession="SRS4330244">
    <IDENTIFIERS>
      <PRIMARY_ID>SRS4330244</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMN10254583</EXTERNAL_ID>
      <EXTERNAL_ID namespace="dbGaP" label="Sample name">1666-WCM154_1_N_WES_Tumor</EXTERNAL_ID>
      <EXTERNAL_ID namespace="phs001666" label="submitted sample id">WCM154_1_N_WES_Tumor</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Adenocarcinoma tumor DNA sample from Bone of a human male participant in the dbGaP study "Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer"</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_accession</TAG>
        <VALUE>phs001666</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitter handle</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study name</TAG>
        <VALUE>Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study design</TAG>
        <VALUE>Case Set</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository sample id</TAG>
        <VALUE>WCM154_1_N_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted sample id</TAG>
        <VALUE>WCM154_1_N_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted subject id</TAG>
        <VALUE>WCM154</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_sample_id</TAG>
        <VALUE>3312217</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_subject_id</TAG>
        <VALUE>2765722</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study disease</TAG>
        <VALUE>Adenocarcinoma</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>body site</TAG>
        <VALUE>Bone</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>histological type</TAG>
        <VALUE>Tissue : Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>analyte type</TAG>
        <VALUE>DNA</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>is tumor</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>subject is affected</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_code</TAG>
        <VALUE>1</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_short_name</TAG>
        <VALUE>HMB-PUB</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="WCM155_1_N_WES_Tumor" accession="SRS4330245">
    <IDENTIFIERS>
      <PRIMARY_ID>SRS4330245</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMN10254548</EXTERNAL_ID>
      <EXTERNAL_ID namespace="dbGaP" label="Sample name">1666-WCM155_1_N_WES_Tumor</EXTERNAL_ID>
      <EXTERNAL_ID namespace="phs001666" label="submitted sample id">WCM155_1_N_WES_Tumor</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Adenocarcinoma tumor DNA sample from Liver of a human male participant in the dbGaP study "Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer"</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_accession</TAG>
        <VALUE>phs001666</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitter handle</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study name</TAG>
        <VALUE>Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study design</TAG>
        <VALUE>Case Set</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository sample id</TAG>
        <VALUE>WCM155_1_N_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted sample id</TAG>
        <VALUE>WCM155_1_N_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted subject id</TAG>
        <VALUE>WCM155</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_sample_id</TAG>
        <VALUE>3312219</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_subject_id</TAG>
        <VALUE>2765723</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study disease</TAG>
        <VALUE>Adenocarcinoma</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>body site</TAG>
        <VALUE>Liver</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>histological type</TAG>
        <VALUE>Tissue : Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>analyte type</TAG>
        <VALUE>DNA</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>is tumor</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>subject is affected</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_code</TAG>
        <VALUE>1</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_short_name</TAG>
        <VALUE>HMB-PUB</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="WCM156_1_C_WES_Tumor" accession="SRS4330246">
    <IDENTIFIERS>
      <PRIMARY_ID>SRS4330246</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMN10254566</EXTERNAL_ID>
      <EXTERNAL_ID namespace="dbGaP" label="Sample name">1666-WCM156_1_C_WES_Tumor</EXTERNAL_ID>
      <EXTERNAL_ID namespace="phs001666" label="submitted sample id">WCM156_1_C_WES_Tumor</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Adenocarcinoma tumor DNA sample from Prostate of a human male participant in the dbGaP study "Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer"</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_accession</TAG>
        <VALUE>phs001666</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitter handle</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study name</TAG>
        <VALUE>Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study design</TAG>
        <VALUE>Case Set</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository sample id</TAG>
        <VALUE>WCM156_1_C_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted sample id</TAG>
        <VALUE>WCM156_1_C_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted subject id</TAG>
        <VALUE>WCM156</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_sample_id</TAG>
        <VALUE>3312220</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_subject_id</TAG>
        <VALUE>2765724</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study disease</TAG>
        <VALUE>Adenocarcinoma</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>body site</TAG>
        <VALUE>Prostate</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>histological type</TAG>
        <VALUE>Tissue : Castrate Resistant Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>analyte type</TAG>
        <VALUE>DNA</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>is tumor</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>subject is affected</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_code</TAG>
        <VALUE>1</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_short_name</TAG>
        <VALUE>HMB-PUB</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="WCM161_1_N_WES_Tumor" accession="SRS4330247">
    <IDENTIFIERS>
      <PRIMARY_ID>SRS4330247</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMN10254563</EXTERNAL_ID>
      <EXTERNAL_ID namespace="dbGaP" label="Sample name">1666-WCM161_1_N_WES_Tumor</EXTERNAL_ID>
      <EXTERNAL_ID namespace="phs001666" label="submitted sample id">WCM161_1_N_WES_Tumor</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Adenocarcinoma tumor DNA sample from Bone of a human male participant in the dbGaP study "Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer"</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_accession</TAG>
        <VALUE>phs001666</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitter handle</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study name</TAG>
        <VALUE>Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study design</TAG>
        <VALUE>Case Set</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository sample id</TAG>
        <VALUE>WCM161_1_N_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted sample id</TAG>
        <VALUE>WCM161_1_N_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted subject id</TAG>
        <VALUE>WCM161</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_sample_id</TAG>
        <VALUE>3312223</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_subject_id</TAG>
        <VALUE>2765725</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study disease</TAG>
        <VALUE>Adenocarcinoma</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>body site</TAG>
        <VALUE>Bone</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>histological type</TAG>
        <VALUE>Tissue : Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>analyte type</TAG>
        <VALUE>DNA</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>is tumor</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>subject is affected</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_code</TAG>
        <VALUE>1</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_short_name</TAG>
        <VALUE>HMB-PUB</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="WCM192_1_N_WES_Tumor" accession="SRS4330248">
    <IDENTIFIERS>
      <PRIMARY_ID>SRS4330248</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMN10254552</EXTERNAL_ID>
      <EXTERNAL_ID namespace="dbGaP" label="Sample name">1666-WCM192_1_N_WES_Tumor</EXTERNAL_ID>
      <EXTERNAL_ID namespace="phs001666" label="submitted sample id">WCM192_1_N_WES_Tumor</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Adenocarcinoma tumor DNA sample from Prostate of a human male participant in the dbGaP study "Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer"</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_accession</TAG>
        <VALUE>phs001666</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitter handle</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study name</TAG>
        <VALUE>Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study design</TAG>
        <VALUE>Case Set</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository sample id</TAG>
        <VALUE>WCM192_1_N_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted sample id</TAG>
        <VALUE>WCM192_1_N_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted subject id</TAG>
        <VALUE>WCM192</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_sample_id</TAG>
        <VALUE>3312225</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_subject_id</TAG>
        <VALUE>2765726</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study disease</TAG>
        <VALUE>Adenocarcinoma</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>body site</TAG>
        <VALUE>Prostate</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>histological type</TAG>
        <VALUE>Tissue : Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>analyte type</TAG>
        <VALUE>DNA</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>is tumor</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>subject is affected</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_code</TAG>
        <VALUE>1</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_short_name</TAG>
        <VALUE>HMB-PUB</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="WCM198_1_N_WES_Tumor" accession="SRS4330249">
    <IDENTIFIERS>
      <PRIMARY_ID>SRS4330249</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMN10254531</EXTERNAL_ID>
      <EXTERNAL_ID namespace="dbGaP" label="Sample name">1666-WCM198_1_N_WES_Tumor</EXTERNAL_ID>
      <EXTERNAL_ID namespace="phs001666" label="submitted sample id">WCM198_1_N_WES_Tumor</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Adenocarcinoma tumor DNA sample from Lymph node of a human male participant in the dbGaP study "Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer"</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_accession</TAG>
        <VALUE>phs001666</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitter handle</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study name</TAG>
        <VALUE>Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study design</TAG>
        <VALUE>Case Set</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository sample id</TAG>
        <VALUE>WCM198_1_N_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted sample id</TAG>
        <VALUE>WCM198_1_N_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted subject id</TAG>
        <VALUE>WCM198</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_sample_id</TAG>
        <VALUE>3312226</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_subject_id</TAG>
        <VALUE>2765727</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study disease</TAG>
        <VALUE>Adenocarcinoma</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>body site</TAG>
        <VALUE>Lymph node</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>histological type</TAG>
        <VALUE>Tissue : Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>analyte type</TAG>
        <VALUE>DNA</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>is tumor</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>subject is affected</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_code</TAG>
        <VALUE>1</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_short_name</TAG>
        <VALUE>HMB-PUB</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="WCM199_1_C_WES_Tumor" accession="SRS4330250">
    <IDENTIFIERS>
      <PRIMARY_ID>SRS4330250</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMN10254556</EXTERNAL_ID>
      <EXTERNAL_ID namespace="dbGaP" label="Sample name">1666-WCM199_1_C_WES_Tumor</EXTERNAL_ID>
      <EXTERNAL_ID namespace="phs001666" label="submitted sample id">WCM199_1_C_WES_Tumor</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Adenocarcinoma tumor DNA sample from Liver of a human male participant in the dbGaP study "Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer"</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_accession</TAG>
        <VALUE>phs001666</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitter handle</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study name</TAG>
        <VALUE>Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study design</TAG>
        <VALUE>Case Set</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository sample id</TAG>
        <VALUE>WCM199_1_C_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted sample id</TAG>
        <VALUE>WCM199_1_C_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted subject id</TAG>
        <VALUE>WCM199</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_sample_id</TAG>
        <VALUE>3312227</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_subject_id</TAG>
        <VALUE>2765728</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study disease</TAG>
        <VALUE>Adenocarcinoma</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>body site</TAG>
        <VALUE>Liver</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>histological type</TAG>
        <VALUE>Tissue : Castrate Resistant Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>analyte type</TAG>
        <VALUE>DNA</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>is tumor</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>subject is affected</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_code</TAG>
        <VALUE>1</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_short_name</TAG>
        <VALUE>HMB-PUB</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="WCM207_1_N_WES_Tumor" accession="SRS4330251">
    <IDENTIFIERS>
      <PRIMARY_ID>SRS4330251</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMN10254573</EXTERNAL_ID>
      <EXTERNAL_ID namespace="dbGaP" label="Sample name">1666-WCM207_1_N_WES_Tumor</EXTERNAL_ID>
      <EXTERNAL_ID namespace="phs001666" label="submitted sample id">WCM207_1_N_WES_Tumor</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Adenocarcinoma tumor DNA sample from Liver of a human male participant in the dbGaP study "Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer"</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_accession</TAG>
        <VALUE>phs001666</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitter handle</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study name</TAG>
        <VALUE>Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study design</TAG>
        <VALUE>Case Set</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository sample id</TAG>
        <VALUE>WCM207_1_N_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted sample id</TAG>
        <VALUE>WCM207_1_N_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted subject id</TAG>
        <VALUE>WCM207</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_sample_id</TAG>
        <VALUE>3312228</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_subject_id</TAG>
        <VALUE>2765729</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study disease</TAG>
        <VALUE>Adenocarcinoma</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>body site</TAG>
        <VALUE>Liver</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>histological type</TAG>
        <VALUE>Tissue : Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>analyte type</TAG>
        <VALUE>DNA</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>is tumor</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>subject is affected</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_code</TAG>
        <VALUE>1</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_short_name</TAG>
        <VALUE>HMB-PUB</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="WCM209_1_C_WES_Tumor" accession="SRS4330252">
    <IDENTIFIERS>
      <PRIMARY_ID>SRS4330252</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMN10254543</EXTERNAL_ID>
      <EXTERNAL_ID namespace="dbGaP" label="Sample name">1666-WCM209_1_C_WES_Tumor</EXTERNAL_ID>
      <EXTERNAL_ID namespace="phs001666" label="submitted sample id">WCM209_1_C_WES_Tumor</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Adenocarcinoma tumor DNA sample from Prostate of a human male participant in the dbGaP study "Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer"</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_accession</TAG>
        <VALUE>phs001666</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitter handle</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study name</TAG>
        <VALUE>Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study design</TAG>
        <VALUE>Case Set</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository sample id</TAG>
        <VALUE>WCM209_1_C_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted sample id</TAG>
        <VALUE>WCM209_1_C_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted subject id</TAG>
        <VALUE>WCM209</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_sample_id</TAG>
        <VALUE>3312230</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_subject_id</TAG>
        <VALUE>2765730</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study disease</TAG>
        <VALUE>Adenocarcinoma</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>body site</TAG>
        <VALUE>Prostate</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>histological type</TAG>
        <VALUE>Tissue : Castrate Resistant Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>analyte type</TAG>
        <VALUE>DNA</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>is tumor</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>subject is affected</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_code</TAG>
        <VALUE>1</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_short_name</TAG>
        <VALUE>HMB-PUB</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="WCM210_1_N_WES_Tumor" accession="SRS4330253">
    <IDENTIFIERS>
      <PRIMARY_ID>SRS4330253</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMN10254526</EXTERNAL_ID>
      <EXTERNAL_ID namespace="dbGaP" label="Sample name">1666-WCM210_1_N_WES_Tumor</EXTERNAL_ID>
      <EXTERNAL_ID namespace="phs001666" label="submitted sample id">WCM210_1_N_WES_Tumor</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Adenocarcinoma tumor DNA sample from Lymph node of a human male participant in the dbGaP study "Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer"</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_accession</TAG>
        <VALUE>phs001666</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitter handle</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study name</TAG>
        <VALUE>Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study design</TAG>
        <VALUE>Case Set</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository sample id</TAG>
        <VALUE>WCM210_1_N_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted sample id</TAG>
        <VALUE>WCM210_1_N_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted subject id</TAG>
        <VALUE>WCM210</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_sample_id</TAG>
        <VALUE>3312232</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_subject_id</TAG>
        <VALUE>2765731</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study disease</TAG>
        <VALUE>Adenocarcinoma</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>body site</TAG>
        <VALUE>Lymph node</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>histological type</TAG>
        <VALUE>Tissue : Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>analyte type</TAG>
        <VALUE>DNA</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>is tumor</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>subject is affected</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_code</TAG>
        <VALUE>1</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_short_name</TAG>
        <VALUE>HMB-PUB</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="WCM213_1_C_WES_Tumor" accession="SRS4330254">
    <IDENTIFIERS>
      <PRIMARY_ID>SRS4330254</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMN10254568</EXTERNAL_ID>
      <EXTERNAL_ID namespace="dbGaP" label="Sample name">1666-WCM213_1_C_WES_Tumor</EXTERNAL_ID>
      <EXTERNAL_ID namespace="phs001666" label="submitted sample id">WCM213_1_C_WES_Tumor</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Adenocarcinoma tumor DNA sample from Liver of a human male participant in the dbGaP study "Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer"</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_accession</TAG>
        <VALUE>phs001666</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitter handle</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study name</TAG>
        <VALUE>Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study design</TAG>
        <VALUE>Case Set</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository sample id</TAG>
        <VALUE>WCM213_1_C_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted sample id</TAG>
        <VALUE>WCM213_1_C_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted subject id</TAG>
        <VALUE>WCM213</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_sample_id</TAG>
        <VALUE>3312234</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_subject_id</TAG>
        <VALUE>2765732</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study disease</TAG>
        <VALUE>Adenocarcinoma</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>body site</TAG>
        <VALUE>Liver</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>histological type</TAG>
        <VALUE>Tissue : Castrate Resistant Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>analyte type</TAG>
        <VALUE>DNA</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>is tumor</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>subject is affected</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_code</TAG>
        <VALUE>1</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_short_name</TAG>
        <VALUE>HMB-PUB</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="WCM221_1_C_WES_Tumor" accession="SRS4330255">
    <IDENTIFIERS>
      <PRIMARY_ID>SRS4330255</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMN10254554</EXTERNAL_ID>
      <EXTERNAL_ID namespace="dbGaP" label="Sample name">1666-WCM221_1_C_WES_Tumor</EXTERNAL_ID>
      <EXTERNAL_ID namespace="phs001666" label="submitted sample id">WCM221_1_C_WES_Tumor</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Adenocarcinoma tumor DNA sample from Liver of a human male participant in the dbGaP study "Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer"</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_accession</TAG>
        <VALUE>phs001666</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitter handle</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study name</TAG>
        <VALUE>Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study design</TAG>
        <VALUE>Case Set</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository sample id</TAG>
        <VALUE>WCM221_1_C_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted sample id</TAG>
        <VALUE>WCM221_1_C_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted subject id</TAG>
        <VALUE>WCM221</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_sample_id</TAG>
        <VALUE>3312235</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_subject_id</TAG>
        <VALUE>2765733</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study disease</TAG>
        <VALUE>Adenocarcinoma</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>body site</TAG>
        <VALUE>Liver</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>histological type</TAG>
        <VALUE>Tissue : Castrate Resistant Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>analyte type</TAG>
        <VALUE>DNA</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>is tumor</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>subject is affected</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_code</TAG>
        <VALUE>1</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_short_name</TAG>
        <VALUE>HMB-PUB</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="WCM252_1_N_WES_Tumor" accession="SRS4330256">
    <IDENTIFIERS>
      <PRIMARY_ID>SRS4330256</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMN10254528</EXTERNAL_ID>
      <EXTERNAL_ID namespace="dbGaP" label="Sample name">1666-WCM252_1_N_WES_Tumor</EXTERNAL_ID>
      <EXTERNAL_ID namespace="phs001666" label="submitted sample id">WCM252_1_N_WES_Tumor</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Adenocarcinoma tumor DNA sample from Liver of a human male participant in the dbGaP study "Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer"</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_accession</TAG>
        <VALUE>phs001666</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitter handle</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study name</TAG>
        <VALUE>Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study design</TAG>
        <VALUE>Case Set</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository sample id</TAG>
        <VALUE>WCM252_1_N_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted sample id</TAG>
        <VALUE>WCM252_1_N_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted subject id</TAG>
        <VALUE>WCM252</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_sample_id</TAG>
        <VALUE>3312237</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_subject_id</TAG>
        <VALUE>2765734</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study disease</TAG>
        <VALUE>Adenocarcinoma</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>body site</TAG>
        <VALUE>Liver</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>histological type</TAG>
        <VALUE>Tissue : Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>analyte type</TAG>
        <VALUE>DNA</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>is tumor</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>subject is affected</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_code</TAG>
        <VALUE>1</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_short_name</TAG>
        <VALUE>HMB-PUB</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="WCM253_1_C_WES_Tumor" accession="SRS4330257">
    <IDENTIFIERS>
      <PRIMARY_ID>SRS4330257</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMN10254551</EXTERNAL_ID>
      <EXTERNAL_ID namespace="dbGaP" label="Sample name">1666-WCM253_1_C_WES_Tumor</EXTERNAL_ID>
      <EXTERNAL_ID namespace="phs001666" label="submitted sample id">WCM253_1_C_WES_Tumor</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Adenocarcinoma tumor DNA sample from Liver of a human male participant in the dbGaP study "Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer"</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_accession</TAG>
        <VALUE>phs001666</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitter handle</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study name</TAG>
        <VALUE>Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study design</TAG>
        <VALUE>Case Set</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository sample id</TAG>
        <VALUE>WCM253_1_C_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted sample id</TAG>
        <VALUE>WCM253_1_C_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted subject id</TAG>
        <VALUE>WCM253</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_sample_id</TAG>
        <VALUE>3312238</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_subject_id</TAG>
        <VALUE>2765735</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study disease</TAG>
        <VALUE>Adenocarcinoma</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>body site</TAG>
        <VALUE>Liver</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>histological type</TAG>
        <VALUE>Tissue : Castrate Resistant Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>analyte type</TAG>
        <VALUE>DNA</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>is tumor</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>subject is affected</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_code</TAG>
        <VALUE>1</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_short_name</TAG>
        <VALUE>HMB-PUB</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="WCM340_1_N_WES_Tumor" accession="SRS4330258">
    <IDENTIFIERS>
      <PRIMARY_ID>SRS4330258</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMN10254545</EXTERNAL_ID>
      <EXTERNAL_ID namespace="dbGaP" label="Sample name">1666-WCM340_1_N_WES_Tumor</EXTERNAL_ID>
      <EXTERNAL_ID namespace="phs001666" label="submitted sample id">WCM340_1_N_WES_Tumor</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Adenocarcinoma tumor DNA sample from Liver of a human male participant in the dbGaP study "Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer"</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_accession</TAG>
        <VALUE>phs001666</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitter handle</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study name</TAG>
        <VALUE>Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study design</TAG>
        <VALUE>Case Set</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository sample id</TAG>
        <VALUE>WCM340_1_N_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted sample id</TAG>
        <VALUE>WCM340_1_N_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted subject id</TAG>
        <VALUE>WCM340</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_sample_id</TAG>
        <VALUE>3312239</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_subject_id</TAG>
        <VALUE>2765736</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study disease</TAG>
        <VALUE>Adenocarcinoma</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>body site</TAG>
        <VALUE>Liver</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>histological type</TAG>
        <VALUE>Tissue : Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>analyte type</TAG>
        <VALUE>DNA</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>is tumor</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>subject is affected</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_code</TAG>
        <VALUE>1</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_short_name</TAG>
        <VALUE>HMB-PUB</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="WCM341_1_C_WES_Tumor" accession="SRS4330259">
    <IDENTIFIERS>
      <PRIMARY_ID>SRS4330259</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMN10254567</EXTERNAL_ID>
      <EXTERNAL_ID namespace="dbGaP" label="Sample name">1666-WCM341_1_C_WES_Tumor</EXTERNAL_ID>
      <EXTERNAL_ID namespace="phs001666" label="submitted sample id">WCM341_1_C_WES_Tumor</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Adenocarcinoma tumor DNA sample from Lymph node of a human male participant in the dbGaP study "Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer"</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_accession</TAG>
        <VALUE>phs001666</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitter handle</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study name</TAG>
        <VALUE>Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study design</TAG>
        <VALUE>Case Set</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository sample id</TAG>
        <VALUE>WCM341_1_C_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted sample id</TAG>
        <VALUE>WCM341_1_C_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted subject id</TAG>
        <VALUE>WCM341</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_sample_id</TAG>
        <VALUE>3312241</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_subject_id</TAG>
        <VALUE>2765737</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study disease</TAG>
        <VALUE>Adenocarcinoma</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>body site</TAG>
        <VALUE>Lymph node</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>histological type</TAG>
        <VALUE>Tissue : Castrate Resistant Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>analyte type</TAG>
        <VALUE>DNA</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>is tumor</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>subject is affected</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_code</TAG>
        <VALUE>1</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_short_name</TAG>
        <VALUE>HMB-PUB</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="WCM343_1_C_WES_Tumor" accession="SRS4330260">
    <IDENTIFIERS>
      <PRIMARY_ID>SRS4330260</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMN10254540</EXTERNAL_ID>
      <EXTERNAL_ID namespace="dbGaP" label="Sample name">1666-WCM343_1_C_WES_Tumor</EXTERNAL_ID>
      <EXTERNAL_ID namespace="phs001666" label="submitted sample id">WCM343_1_C_WES_Tumor</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Adenocarcinoma tumor DNA sample from Lymph node of a human male participant in the dbGaP study "Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer"</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_accession</TAG>
        <VALUE>phs001666</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitter handle</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study name</TAG>
        <VALUE>Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study design</TAG>
        <VALUE>Case Set</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository sample id</TAG>
        <VALUE>WCM343_1_C_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted sample id</TAG>
        <VALUE>WCM343_1_C_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted subject id</TAG>
        <VALUE>WCM343</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_sample_id</TAG>
        <VALUE>3312242</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_subject_id</TAG>
        <VALUE>2765738</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study disease</TAG>
        <VALUE>Adenocarcinoma</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>body site</TAG>
        <VALUE>Lymph node</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>histological type</TAG>
        <VALUE>Tissue : Castrate Resistant Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>analyte type</TAG>
        <VALUE>DNA</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>is tumor</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>subject is affected</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_code</TAG>
        <VALUE>1</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_short_name</TAG>
        <VALUE>HMB-PUB</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="WCM367_1_C_WES_Tumor" accession="SRS4330261">
    <IDENTIFIERS>
      <PRIMARY_ID>SRS4330261</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMN10254574</EXTERNAL_ID>
      <EXTERNAL_ID namespace="dbGaP" label="Sample name">1666-WCM367_1_C_WES_Tumor</EXTERNAL_ID>
      <EXTERNAL_ID namespace="phs001666" label="submitted sample id">WCM367_1_C_WES_Tumor</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Adenocarcinoma tumor DNA sample from Peri-Rectal Mass of a human male participant in the dbGaP study "Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer"</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_accession</TAG>
        <VALUE>phs001666</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitter handle</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study name</TAG>
        <VALUE>Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study design</TAG>
        <VALUE>Case Set</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository sample id</TAG>
        <VALUE>WCM367_1_C_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted sample id</TAG>
        <VALUE>WCM367_1_C_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted subject id</TAG>
        <VALUE>WCM367</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_sample_id</TAG>
        <VALUE>3312243</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_subject_id</TAG>
        <VALUE>2765739</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study disease</TAG>
        <VALUE>Adenocarcinoma</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>body site</TAG>
        <VALUE>Peri-Rectal Mass</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>histological type</TAG>
        <VALUE>Tissue : Castrate Resistant Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>analyte type</TAG>
        <VALUE>DNA</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>is tumor</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>subject is affected</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_code</TAG>
        <VALUE>1</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_short_name</TAG>
        <VALUE>HMB-PUB</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="WCM373_1_C_WES_Tumor" accession="SRS4330262">
    <IDENTIFIERS>
      <PRIMARY_ID>SRS4330262</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMN10254582</EXTERNAL_ID>
      <EXTERNAL_ID namespace="dbGaP" label="Sample name">1666-WCM373_1_C_WES_Tumor</EXTERNAL_ID>
      <EXTERNAL_ID namespace="phs001666" label="submitted sample id">WCM373_1_C_WES_Tumor</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Adenocarcinoma tumor DNA sample from Liver of a human male participant in the dbGaP study "Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer"</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_accession</TAG>
        <VALUE>phs001666</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitter handle</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study name</TAG>
        <VALUE>Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study design</TAG>
        <VALUE>Case Set</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository sample id</TAG>
        <VALUE>WCM373_1_C_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted sample id</TAG>
        <VALUE>WCM373_1_C_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted subject id</TAG>
        <VALUE>WCM373</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_sample_id</TAG>
        <VALUE>3312245</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_subject_id</TAG>
        <VALUE>2765740</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study disease</TAG>
        <VALUE>Adenocarcinoma</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>body site</TAG>
        <VALUE>Liver</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>histological type</TAG>
        <VALUE>Tissue : Castrate Resistant Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>analyte type</TAG>
        <VALUE>DNA</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>is tumor</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>subject is affected</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_code</TAG>
        <VALUE>1</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_short_name</TAG>
        <VALUE>HMB-PUB</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="WCM405_1_C_WES_Tumor" accession="SRS4330263">
    <IDENTIFIERS>
      <PRIMARY_ID>SRS4330263</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMN10254527</EXTERNAL_ID>
      <EXTERNAL_ID namespace="dbGaP" label="Sample name">1666-WCM405_1_C_WES_Tumor</EXTERNAL_ID>
      <EXTERNAL_ID namespace="phs001666" label="submitted sample id">WCM405_1_C_WES_Tumor</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Adenocarcinoma tumor DNA sample from Liver of a human male participant in the dbGaP study "Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer"</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_accession</TAG>
        <VALUE>phs001666</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitter handle</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study name</TAG>
        <VALUE>Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study design</TAG>
        <VALUE>Case Set</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository sample id</TAG>
        <VALUE>WCM405_1_C_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted sample id</TAG>
        <VALUE>WCM405_1_C_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted subject id</TAG>
        <VALUE>WCM405</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_sample_id</TAG>
        <VALUE>3312246</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_subject_id</TAG>
        <VALUE>2765741</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study disease</TAG>
        <VALUE>Adenocarcinoma</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>body site</TAG>
        <VALUE>Liver</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>histological type</TAG>
        <VALUE>Tissue : Castrate Resistant Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>analyte type</TAG>
        <VALUE>DNA</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>is tumor</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>subject is affected</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_code</TAG>
        <VALUE>1</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_short_name</TAG>
        <VALUE>HMB-PUB</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="WCM423_1_C_WES_Tumor" accession="SRS4330264">
    <IDENTIFIERS>
      <PRIMARY_ID>SRS4330264</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMN10254530</EXTERNAL_ID>
      <EXTERNAL_ID namespace="dbGaP" label="Sample name">1666-WCM423_1_C_WES_Tumor</EXTERNAL_ID>
      <EXTERNAL_ID namespace="phs001666" label="submitted sample id">WCM423_1_C_WES_Tumor</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Adenocarcinoma tumor DNA sample from Liver of a human male participant in the dbGaP study "Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer"</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_accession</TAG>
        <VALUE>phs001666</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitter handle</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study name</TAG>
        <VALUE>Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study design</TAG>
        <VALUE>Case Set</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository sample id</TAG>
        <VALUE>WCM423_1_C_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted sample id</TAG>
        <VALUE>WCM423_1_C_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted subject id</TAG>
        <VALUE>WCM423</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_sample_id</TAG>
        <VALUE>3312248</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_subject_id</TAG>
        <VALUE>2765742</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study disease</TAG>
        <VALUE>Adenocarcinoma</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>body site</TAG>
        <VALUE>Liver</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>histological type</TAG>
        <VALUE>Tissue : Castrate Resistant Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>analyte type</TAG>
        <VALUE>DNA</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>is tumor</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>subject is affected</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_code</TAG>
        <VALUE>1</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_short_name</TAG>
        <VALUE>HMB-PUB</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="WCM509_1_C_WES_Tumor" accession="SRS4330265">
    <IDENTIFIERS>
      <PRIMARY_ID>SRS4330265</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMN10254581</EXTERNAL_ID>
      <EXTERNAL_ID namespace="dbGaP" label="Sample name">1666-WCM509_1_C_WES_Tumor</EXTERNAL_ID>
      <EXTERNAL_ID namespace="phs001666" label="submitted sample id">WCM509_1_C_WES_Tumor</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Adenocarcinoma tumor DNA sample from Lymph node, retrperitoneal of a human male participant in the dbGaP study "Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer"</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_accession</TAG>
        <VALUE>phs001666</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitter handle</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study name</TAG>
        <VALUE>Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study design</TAG>
        <VALUE>Case Set</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository sample id</TAG>
        <VALUE>WCM509_1_C_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted sample id</TAG>
        <VALUE>WCM509_1_C_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted subject id</TAG>
        <VALUE>WCM509</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_sample_id</TAG>
        <VALUE>3312249</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_subject_id</TAG>
        <VALUE>2765743</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study disease</TAG>
        <VALUE>Adenocarcinoma</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>body site</TAG>
        <VALUE>Lymph node, retrperitoneal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>histological type</TAG>
        <VALUE>Tissue : Castrate Resistant Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>analyte type</TAG>
        <VALUE>DNA</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>is tumor</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>subject is affected</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_code</TAG>
        <VALUE>1</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_short_name</TAG>
        <VALUE>HMB-PUB</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="WCM554_1_C_WES_Tumor" accession="SRS4330266">
    <IDENTIFIERS>
      <PRIMARY_ID>SRS4330266</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMN10254558</EXTERNAL_ID>
      <EXTERNAL_ID namespace="dbGaP" label="Sample name">1666-WCM554_1_C_WES_Tumor</EXTERNAL_ID>
      <EXTERNAL_ID namespace="phs001666" label="submitted sample id">WCM554_1_C_WES_Tumor</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Adenocarcinoma tumor DNA sample from Lymph node of a human male participant in the dbGaP study "Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer"</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_accession</TAG>
        <VALUE>phs001666</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitter handle</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study name</TAG>
        <VALUE>Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study design</TAG>
        <VALUE>Case Set</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository sample id</TAG>
        <VALUE>WCM554_1_C_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted sample id</TAG>
        <VALUE>WCM554_1_C_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted subject id</TAG>
        <VALUE>WCM554</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_sample_id</TAG>
        <VALUE>3312250</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_subject_id</TAG>
        <VALUE>2765744</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study disease</TAG>
        <VALUE>Adenocarcinoma</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>body site</TAG>
        <VALUE>Lymph node</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>histological type</TAG>
        <VALUE>Tissue : Castrate Resistant Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>analyte type</TAG>
        <VALUE>DNA</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>is tumor</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>subject is affected</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_code</TAG>
        <VALUE>1</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_short_name</TAG>
        <VALUE>HMB-PUB</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="WCM555_1_C_WES_Tumor" accession="SRS4330267">
    <IDENTIFIERS>
      <PRIMARY_ID>SRS4330267</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMN10254569</EXTERNAL_ID>
      <EXTERNAL_ID namespace="dbGaP" label="Sample name">1666-WCM555_1_C_WES_Tumor</EXTERNAL_ID>
      <EXTERNAL_ID namespace="phs001666" label="submitted sample id">WCM555_1_C_WES_Tumor</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Adenocarcinoma tumor DNA sample from Liver of a human male participant in the dbGaP study "Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer"</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_accession</TAG>
        <VALUE>phs001666</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitter handle</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study name</TAG>
        <VALUE>Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study design</TAG>
        <VALUE>Case Set</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository sample id</TAG>
        <VALUE>WCM555_1_C_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted sample id</TAG>
        <VALUE>WCM555_1_C_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted subject id</TAG>
        <VALUE>WCM555</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_sample_id</TAG>
        <VALUE>3312251</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_subject_id</TAG>
        <VALUE>2765745</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study disease</TAG>
        <VALUE>Adenocarcinoma</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>body site</TAG>
        <VALUE>Liver</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>histological type</TAG>
        <VALUE>Tissue : Castrate Resistant Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>analyte type</TAG>
        <VALUE>DNA</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>is tumor</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>subject is affected</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_code</TAG>
        <VALUE>1</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_short_name</TAG>
        <VALUE>HMB-PUB</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="WCM556_1_C_WES_Tumor" accession="SRS4330268">
    <IDENTIFIERS>
      <PRIMARY_ID>SRS4330268</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMN10254575</EXTERNAL_ID>
      <EXTERNAL_ID namespace="dbGaP" label="Sample name">1666-WCM556_1_C_WES_Tumor</EXTERNAL_ID>
      <EXTERNAL_ID namespace="phs001666" label="submitted sample id">WCM556_1_C_WES_Tumor</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Adenocarcinoma tumor DNA sample from Prostate of a human male participant in the dbGaP study "Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer"</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_accession</TAG>
        <VALUE>phs001666</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitter handle</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study name</TAG>
        <VALUE>Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study design</TAG>
        <VALUE>Case Set</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository sample id</TAG>
        <VALUE>WCM556_1_C_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted sample id</TAG>
        <VALUE>WCM556_1_C_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted subject id</TAG>
        <VALUE>WCM556</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_sample_id</TAG>
        <VALUE>3312253</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_subject_id</TAG>
        <VALUE>2765746</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study disease</TAG>
        <VALUE>Adenocarcinoma</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>body site</TAG>
        <VALUE>Prostate</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>histological type</TAG>
        <VALUE>Tissue : Castrate Resistant Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>analyte type</TAG>
        <VALUE>DNA</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>is tumor</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>subject is affected</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_code</TAG>
        <VALUE>1</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_short_name</TAG>
        <VALUE>HMB-PUB</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="WCM572_1_C_WES_Tumor" accession="SRS4330269">
    <IDENTIFIERS>
      <PRIMARY_ID>SRS4330269</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMN10254553</EXTERNAL_ID>
      <EXTERNAL_ID namespace="dbGaP" label="Sample name">1666-WCM572_1_C_WES_Tumor</EXTERNAL_ID>
      <EXTERNAL_ID namespace="phs001666" label="submitted sample id">WCM572_1_C_WES_Tumor</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Adenocarcinoma tumor DNA sample from Liver of a human male participant in the dbGaP study "Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer"</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_accession</TAG>
        <VALUE>phs001666</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitter handle</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study name</TAG>
        <VALUE>Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study design</TAG>
        <VALUE>Case Set</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository sample id</TAG>
        <VALUE>WCM572_1_C_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted sample id</TAG>
        <VALUE>WCM572_1_C_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted subject id</TAG>
        <VALUE>WCM572</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_sample_id</TAG>
        <VALUE>3312254</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_subject_id</TAG>
        <VALUE>2765747</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study disease</TAG>
        <VALUE>Adenocarcinoma</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>body site</TAG>
        <VALUE>Liver</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>histological type</TAG>
        <VALUE>Tissue : Castrate Resistant Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>analyte type</TAG>
        <VALUE>DNA</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>is tumor</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>subject is affected</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_code</TAG>
        <VALUE>1</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_short_name</TAG>
        <VALUE>HMB-PUB</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="WCM573_1_N_WES_Tumor" accession="SRS4330270">
    <IDENTIFIERS>
      <PRIMARY_ID>SRS4330270</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMN10254586</EXTERNAL_ID>
      <EXTERNAL_ID namespace="dbGaP" label="Sample name">1666-WCM573_1_N_WES_Tumor</EXTERNAL_ID>
      <EXTERNAL_ID namespace="phs001666" label="submitted sample id">WCM573_1_N_WES_Tumor</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Adenocarcinoma tumor DNA sample from Soft tissue of a human male participant in the dbGaP study "Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer"</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_accession</TAG>
        <VALUE>phs001666</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitter handle</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study name</TAG>
        <VALUE>Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study design</TAG>
        <VALUE>Case Set</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository sample id</TAG>
        <VALUE>WCM573_1_N_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted sample id</TAG>
        <VALUE>WCM573_1_N_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted subject id</TAG>
        <VALUE>WCM573</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_sample_id</TAG>
        <VALUE>3312256</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_subject_id</TAG>
        <VALUE>2765748</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study disease</TAG>
        <VALUE>Adenocarcinoma</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>body site</TAG>
        <VALUE>Soft tissue</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>histological type</TAG>
        <VALUE>Tissue : Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>analyte type</TAG>
        <VALUE>DNA</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>is tumor</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>subject is affected</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_code</TAG>
        <VALUE>1</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_short_name</TAG>
        <VALUE>HMB-PUB</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="WCM6_1_C_WES_Tumor" accession="SRS4330271">
    <IDENTIFIERS>
      <PRIMARY_ID>SRS4330271</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMN10254570</EXTERNAL_ID>
      <EXTERNAL_ID namespace="dbGaP" label="Sample name">1666-WCM6_1_C_WES_Tumor</EXTERNAL_ID>
      <EXTERNAL_ID namespace="phs001666" label="submitted sample id">WCM6_1_C_WES_Tumor</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Adenocarcinoma tumor DNA sample from LN of a human male participant in the dbGaP study "Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer"</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_accession</TAG>
        <VALUE>phs001666</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitter handle</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study name</TAG>
        <VALUE>Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study design</TAG>
        <VALUE>Case Set</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository sample id</TAG>
        <VALUE>WCM6_1_C_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted sample id</TAG>
        <VALUE>WCM6_1_C_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted subject id</TAG>
        <VALUE>WCM6</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_sample_id</TAG>
        <VALUE>3312275</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_subject_id</TAG>
        <VALUE>2765749</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study disease</TAG>
        <VALUE>Adenocarcinoma</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>body site</TAG>
        <VALUE>LN</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>histological type</TAG>
        <VALUE>Tissue : Castrate Resistant Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>analyte type</TAG>
        <VALUE>DNA</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>is tumor</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>subject is affected</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_code</TAG>
        <VALUE>1</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_short_name</TAG>
        <VALUE>HMB-PUB</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="WCM646_1_N_WES_Tumor" accession="SRS4330272">
    <IDENTIFIERS>
      <PRIMARY_ID>SRS4330272</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMN10254542</EXTERNAL_ID>
      <EXTERNAL_ID namespace="dbGaP" label="Sample name">1666-WCM646_1_N_WES_Tumor</EXTERNAL_ID>
      <EXTERNAL_ID namespace="phs001666" label="submitted sample id">WCM646_1_N_WES_Tumor</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Adenocarcinoma tumor DNA sample from Lymph node of a human male participant in the dbGaP study "Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer"</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_accession</TAG>
        <VALUE>phs001666</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitter handle</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study name</TAG>
        <VALUE>Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study design</TAG>
        <VALUE>Case Set</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository sample id</TAG>
        <VALUE>WCM646_1_N_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted sample id</TAG>
        <VALUE>WCM646_1_N_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted subject id</TAG>
        <VALUE>WCM646</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_sample_id</TAG>
        <VALUE>3312257</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_subject_id</TAG>
        <VALUE>2765750</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study disease</TAG>
        <VALUE>Adenocarcinoma</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>body site</TAG>
        <VALUE>Lymph node</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>histological type</TAG>
        <VALUE>Tissue : Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>analyte type</TAG>
        <VALUE>DNA</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>is tumor</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>subject is affected</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_code</TAG>
        <VALUE>1</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_short_name</TAG>
        <VALUE>HMB-PUB</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="WCM647_1_N_WES_Tumor" accession="SRS4330273">
    <IDENTIFIERS>
      <PRIMARY_ID>SRS4330273</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMN10254559</EXTERNAL_ID>
      <EXTERNAL_ID namespace="dbGaP" label="Sample name">1666-WCM647_1_N_WES_Tumor</EXTERNAL_ID>
      <EXTERNAL_ID namespace="phs001666" label="submitted sample id">WCM647_1_N_WES_Tumor</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Adenocarcinoma tumor DNA sample from Liver of a human male participant in the dbGaP study "Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer"</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_accession</TAG>
        <VALUE>phs001666</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitter handle</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study name</TAG>
        <VALUE>Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study design</TAG>
        <VALUE>Case Set</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository sample id</TAG>
        <VALUE>WCM647_1_N_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted sample id</TAG>
        <VALUE>WCM647_1_N_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted subject id</TAG>
        <VALUE>WCM647</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_sample_id</TAG>
        <VALUE>3312258</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_subject_id</TAG>
        <VALUE>2765751</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study disease</TAG>
        <VALUE>Adenocarcinoma</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>body site</TAG>
        <VALUE>Liver</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>histological type</TAG>
        <VALUE>Tissue : Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>analyte type</TAG>
        <VALUE>DNA</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>is tumor</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>subject is affected</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_code</TAG>
        <VALUE>1</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_short_name</TAG>
        <VALUE>HMB-PUB</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="WCM648_1_C_WES_Tumor" accession="SRS4330274">
    <IDENTIFIERS>
      <PRIMARY_ID>SRS4330274</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMN10254557</EXTERNAL_ID>
      <EXTERNAL_ID namespace="dbGaP" label="Sample name">1666-WCM648_1_C_WES_Tumor</EXTERNAL_ID>
      <EXTERNAL_ID namespace="phs001666" label="submitted sample id">WCM648_1_C_WES_Tumor</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Adenocarcinoma tumor DNA sample from RP mass of a human male participant in the dbGaP study "Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer"</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_accession</TAG>
        <VALUE>phs001666</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitter handle</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study name</TAG>
        <VALUE>Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study design</TAG>
        <VALUE>Case Set</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository sample id</TAG>
        <VALUE>WCM648_1_C_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted sample id</TAG>
        <VALUE>WCM648_1_C_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted subject id</TAG>
        <VALUE>WCM648</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_sample_id</TAG>
        <VALUE>3312259</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_subject_id</TAG>
        <VALUE>2765752</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study disease</TAG>
        <VALUE>Adenocarcinoma</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>body site</TAG>
        <VALUE>RP mass</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>histological type</TAG>
        <VALUE>Tissue : Castrate Resistant Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>analyte type</TAG>
        <VALUE>DNA</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>is tumor</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>subject is affected</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_code</TAG>
        <VALUE>1</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_short_name</TAG>
        <VALUE>HMB-PUB</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="WCM650_1_N_WES_Tumor" accession="SRS4330275">
    <IDENTIFIERS>
      <PRIMARY_ID>SRS4330275</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMN10254547</EXTERNAL_ID>
      <EXTERNAL_ID namespace="dbGaP" label="Sample name">1666-WCM650_1_N_WES_Tumor</EXTERNAL_ID>
      <EXTERNAL_ID namespace="phs001666" label="submitted sample id">WCM650_1_N_WES_Tumor</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Adenocarcinoma tumor DNA sample from Right flank mass of a human male participant in the dbGaP study "Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer"</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_accession</TAG>
        <VALUE>phs001666</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitter handle</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study name</TAG>
        <VALUE>Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study design</TAG>
        <VALUE>Case Set</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository sample id</TAG>
        <VALUE>WCM650_1_N_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted sample id</TAG>
        <VALUE>WCM650_1_N_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted subject id</TAG>
        <VALUE>WCM650</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_sample_id</TAG>
        <VALUE>3312260</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_subject_id</TAG>
        <VALUE>2765753</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study disease</TAG>
        <VALUE>Adenocarcinoma</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>body site</TAG>
        <VALUE>Right flank mass</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>histological type</TAG>
        <VALUE>Tissue : Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>analyte type</TAG>
        <VALUE>DNA</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>is tumor</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>subject is affected</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_code</TAG>
        <VALUE>1</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_short_name</TAG>
        <VALUE>HMB-PUB</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="WCM653_1_N_WES_Tumor" accession="SRS4330276">
    <IDENTIFIERS>
      <PRIMARY_ID>SRS4330276</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMN10254546</EXTERNAL_ID>
      <EXTERNAL_ID namespace="dbGaP" label="Sample name">1666-WCM653_1_N_WES_Tumor</EXTERNAL_ID>
      <EXTERNAL_ID namespace="phs001666" label="submitted sample id">WCM653_1_N_WES_Tumor</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Adenocarcinoma tumor DNA sample from Pelvic Mass of a human male participant in the dbGaP study "Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer"</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_accession</TAG>
        <VALUE>phs001666</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitter handle</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study name</TAG>
        <VALUE>Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study design</TAG>
        <VALUE>Case Set</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository sample id</TAG>
        <VALUE>WCM653_1_N_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted sample id</TAG>
        <VALUE>WCM653_1_N_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted subject id</TAG>
        <VALUE>WCM653</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_sample_id</TAG>
        <VALUE>3312261</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_subject_id</TAG>
        <VALUE>2765754</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study disease</TAG>
        <VALUE>Adenocarcinoma</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>body site</TAG>
        <VALUE>Pelvic Mass</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>histological type</TAG>
        <VALUE>Tissue : Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>analyte type</TAG>
        <VALUE>DNA</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>is tumor</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>subject is affected</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_code</TAG>
        <VALUE>1</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_short_name</TAG>
        <VALUE>HMB-PUB</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="WCM654_1_N_WES_Tumor" accession="SRS4330277">
    <IDENTIFIERS>
      <PRIMARY_ID>SRS4330277</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMN10254532</EXTERNAL_ID>
      <EXTERNAL_ID namespace="dbGaP" label="Sample name">1666-WCM654_1_N_WES_Tumor</EXTERNAL_ID>
      <EXTERNAL_ID namespace="phs001666" label="submitted sample id">WCM654_1_N_WES_Tumor</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Adenocarcinoma tumor DNA sample from Liver of a human male participant in the dbGaP study "Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer"</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_accession</TAG>
        <VALUE>phs001666</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitter handle</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study name</TAG>
        <VALUE>Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study design</TAG>
        <VALUE>Case Set</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository sample id</TAG>
        <VALUE>WCM654_1_N_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted sample id</TAG>
        <VALUE>WCM654_1_N_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted subject id</TAG>
        <VALUE>WCM654</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_sample_id</TAG>
        <VALUE>3312262</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_subject_id</TAG>
        <VALUE>2765755</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study disease</TAG>
        <VALUE>Adenocarcinoma</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>body site</TAG>
        <VALUE>Liver</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>histological type</TAG>
        <VALUE>Tissue : Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>analyte type</TAG>
        <VALUE>DNA</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>is tumor</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>subject is affected</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_code</TAG>
        <VALUE>1</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_short_name</TAG>
        <VALUE>HMB-PUB</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="WCM655_1_N_WES_Tumor" accession="SRS4330278">
    <IDENTIFIERS>
      <PRIMARY_ID>SRS4330278</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMN10254578</EXTERNAL_ID>
      <EXTERNAL_ID namespace="dbGaP" label="Sample name">1666-WCM655_1_N_WES_Tumor</EXTERNAL_ID>
      <EXTERNAL_ID namespace="phs001666" label="submitted sample id">WCM655_1_N_WES_Tumor</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Adenocarcinoma tumor DNA sample from Liver of a human male participant in the dbGaP study "Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer"</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_accession</TAG>
        <VALUE>phs001666</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitter handle</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study name</TAG>
        <VALUE>Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study design</TAG>
        <VALUE>Case Set</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository sample id</TAG>
        <VALUE>WCM655_1_N_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted sample id</TAG>
        <VALUE>WCM655_1_N_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted subject id</TAG>
        <VALUE>WCM655</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_sample_id</TAG>
        <VALUE>3312263</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_subject_id</TAG>
        <VALUE>2765756</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study disease</TAG>
        <VALUE>Adenocarcinoma</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>body site</TAG>
        <VALUE>Liver</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>histological type</TAG>
        <VALUE>Tissue : Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>analyte type</TAG>
        <VALUE>DNA</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>is tumor</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>subject is affected</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_code</TAG>
        <VALUE>1</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_short_name</TAG>
        <VALUE>HMB-PUB</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="WCM657_1_C_WES_Tumor" accession="SRS4330279">
    <IDENTIFIERS>
      <PRIMARY_ID>SRS4330279</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMN10254544</EXTERNAL_ID>
      <EXTERNAL_ID namespace="dbGaP" label="Sample name">1666-WCM657_1_C_WES_Tumor</EXTERNAL_ID>
      <EXTERNAL_ID namespace="phs001666" label="submitted sample id">WCM657_1_C_WES_Tumor</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Adenocarcinoma tumor DNA sample from Prostate of a human male participant in the dbGaP study "Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer"</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_accession</TAG>
        <VALUE>phs001666</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitter handle</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study name</TAG>
        <VALUE>Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study design</TAG>
        <VALUE>Case Set</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository sample id</TAG>
        <VALUE>WCM657_1_C_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted sample id</TAG>
        <VALUE>WCM657_1_C_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted subject id</TAG>
        <VALUE>WCM657</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_sample_id</TAG>
        <VALUE>3312264</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_subject_id</TAG>
        <VALUE>2765757</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study disease</TAG>
        <VALUE>Adenocarcinoma</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>body site</TAG>
        <VALUE>Prostate</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>histological type</TAG>
        <VALUE>Tissue : Castrate Resistant Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>analyte type</TAG>
        <VALUE>DNA</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>is tumor</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>subject is affected</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_code</TAG>
        <VALUE>1</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_short_name</TAG>
        <VALUE>HMB-PUB</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="WCM658_1_N_WES_Tumor" accession="SRS4330280">
    <IDENTIFIERS>
      <PRIMARY_ID>SRS4330280</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMN10254535</EXTERNAL_ID>
      <EXTERNAL_ID namespace="dbGaP" label="Sample name">1666-WCM658_1_N_WES_Tumor</EXTERNAL_ID>
      <EXTERNAL_ID namespace="phs001666" label="submitted sample id">WCM658_1_N_WES_Tumor</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Adenocarcinoma tumor DNA sample from Liver of a human male participant in the dbGaP study "Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer"</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_accession</TAG>
        <VALUE>phs001666</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitter handle</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study name</TAG>
        <VALUE>Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study design</TAG>
        <VALUE>Case Set</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository sample id</TAG>
        <VALUE>WCM658_1_N_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted sample id</TAG>
        <VALUE>WCM658_1_N_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted subject id</TAG>
        <VALUE>WCM658</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_sample_id</TAG>
        <VALUE>3312265</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_subject_id</TAG>
        <VALUE>2765758</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study disease</TAG>
        <VALUE>Adenocarcinoma</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>body site</TAG>
        <VALUE>Liver</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>histological type</TAG>
        <VALUE>Tissue : Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>analyte type</TAG>
        <VALUE>DNA</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>is tumor</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>subject is affected</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_code</TAG>
        <VALUE>1</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_short_name</TAG>
        <VALUE>HMB-PUB</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="WCM662_1_C_WES_Tumor" accession="SRS4330281">
    <IDENTIFIERS>
      <PRIMARY_ID>SRS4330281</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMN10254560</EXTERNAL_ID>
      <EXTERNAL_ID namespace="dbGaP" label="Sample name">1666-WCM662_1_C_WES_Tumor</EXTERNAL_ID>
      <EXTERNAL_ID namespace="phs001666" label="submitted sample id">WCM662_1_C_WES_Tumor</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Adenocarcinoma tumor DNA sample from Lymph node of a human male participant in the dbGaP study "Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer"</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_accession</TAG>
        <VALUE>phs001666</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitter handle</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study name</TAG>
        <VALUE>Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study design</TAG>
        <VALUE>Case Set</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository sample id</TAG>
        <VALUE>WCM662_1_C_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted sample id</TAG>
        <VALUE>WCM662_1_C_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted subject id</TAG>
        <VALUE>WCM662</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_sample_id</TAG>
        <VALUE>3312266</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_subject_id</TAG>
        <VALUE>2765759</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study disease</TAG>
        <VALUE>Adenocarcinoma</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>body site</TAG>
        <VALUE>Lymph node</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>histological type</TAG>
        <VALUE>Tissue : Castrate Resistant Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>analyte type</TAG>
        <VALUE>DNA</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>is tumor</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>subject is affected</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_code</TAG>
        <VALUE>1</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_short_name</TAG>
        <VALUE>HMB-PUB</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="WCM663_1_C_WES_Tumor" accession="SRS4330282">
    <IDENTIFIERS>
      <PRIMARY_ID>SRS4330282</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMN10254533</EXTERNAL_ID>
      <EXTERNAL_ID namespace="dbGaP" label="Sample name">1666-WCM663_1_C_WES_Tumor</EXTERNAL_ID>
      <EXTERNAL_ID namespace="phs001666" label="submitted sample id">WCM663_1_C_WES_Tumor</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Adenocarcinoma tumor DNA sample from Lymph node of a human male participant in the dbGaP study "Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer"</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_accession</TAG>
        <VALUE>phs001666</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitter handle</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study name</TAG>
        <VALUE>Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study design</TAG>
        <VALUE>Case Set</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository sample id</TAG>
        <VALUE>WCM663_1_C_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted sample id</TAG>
        <VALUE>WCM663_1_C_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted subject id</TAG>
        <VALUE>WCM663</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_sample_id</TAG>
        <VALUE>3312267</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_subject_id</TAG>
        <VALUE>2765760</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study disease</TAG>
        <VALUE>Adenocarcinoma</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>body site</TAG>
        <VALUE>Lymph node</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>histological type</TAG>
        <VALUE>Tissue : Castrate Resistant Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>analyte type</TAG>
        <VALUE>DNA</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>is tumor</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>subject is affected</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_code</TAG>
        <VALUE>1</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_short_name</TAG>
        <VALUE>HMB-PUB</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="WCM664_1_C_WES_Tumor" accession="SRS4330283">
    <IDENTIFIERS>
      <PRIMARY_ID>SRS4330283</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMN10254525</EXTERNAL_ID>
      <EXTERNAL_ID namespace="dbGaP" label="Sample name">1666-WCM664_1_C_WES_Tumor</EXTERNAL_ID>
      <EXTERNAL_ID namespace="phs001666" label="submitted sample id">WCM664_1_C_WES_Tumor</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Adenocarcinoma tumor DNA sample from Lymph node of a human male participant in the dbGaP study "Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer"</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_accession</TAG>
        <VALUE>phs001666</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitter handle</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study name</TAG>
        <VALUE>Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study design</TAG>
        <VALUE>Case Set</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository sample id</TAG>
        <VALUE>WCM664_1_C_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted sample id</TAG>
        <VALUE>WCM664_1_C_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted subject id</TAG>
        <VALUE>WCM664</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_sample_id</TAG>
        <VALUE>3312268</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_subject_id</TAG>
        <VALUE>2765761</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study disease</TAG>
        <VALUE>Adenocarcinoma</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>body site</TAG>
        <VALUE>Lymph node</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>histological type</TAG>
        <VALUE>Tissue : Castrate Resistant Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>analyte type</TAG>
        <VALUE>DNA</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>is tumor</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>subject is affected</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_code</TAG>
        <VALUE>1</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_short_name</TAG>
        <VALUE>HMB-PUB</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="WCM886_1_N_WES_Tumor" accession="SRS4330284">
    <IDENTIFIERS>
      <PRIMARY_ID>SRS4330284</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMN10254579</EXTERNAL_ID>
      <EXTERNAL_ID namespace="dbGaP" label="Sample name">1666-WCM886_1_N_WES_Tumor</EXTERNAL_ID>
      <EXTERNAL_ID namespace="phs001666" label="submitted sample id">WCM886_1_N_WES_Tumor</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Adenocarcinoma tumor DNA sample from Brain of a human male participant in the dbGaP study "Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer"</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_accession</TAG>
        <VALUE>phs001666</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitter handle</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study name</TAG>
        <VALUE>Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study design</TAG>
        <VALUE>Case Set</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository sample id</TAG>
        <VALUE>WCM886_1_N_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted sample id</TAG>
        <VALUE>WCM886_1_N_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted subject id</TAG>
        <VALUE>WCM886</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_sample_id</TAG>
        <VALUE>3312279</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_subject_id</TAG>
        <VALUE>2765768</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study disease</TAG>
        <VALUE>Adenocarcinoma</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>body site</TAG>
        <VALUE>Brain</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>histological type</TAG>
        <VALUE>Tissue : Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>analyte type</TAG>
        <VALUE>DNA</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>is tumor</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>subject is affected</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_code</TAG>
        <VALUE>1</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_short_name</TAG>
        <VALUE>HMB-PUB</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="WCM155_1_N_RNA_Tumor" accession="SRS4330285">
    <IDENTIFIERS>
      <PRIMARY_ID>SRS4330285</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMN10254572</EXTERNAL_ID>
      <EXTERNAL_ID namespace="dbGaP" label="Sample name">1666-WCM155_1_N_RNA_Tumor</EXTERNAL_ID>
      <EXTERNAL_ID namespace="phs001666" label="submitted sample id">WCM155_1_N_RNA_Tumor</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Adenocarcinoma tumor RNA sample from Liver of a human male participant in the dbGaP study "Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer"</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_accession</TAG>
        <VALUE>phs001666</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitter handle</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study name</TAG>
        <VALUE>Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study design</TAG>
        <VALUE>Case Set</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository sample id</TAG>
        <VALUE>WCM155_1_N_RNA_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted sample id</TAG>
        <VALUE>WCM155_1_N_RNA_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted subject id</TAG>
        <VALUE>WCM155</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_sample_id</TAG>
        <VALUE>3312218</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_subject_id</TAG>
        <VALUE>2765723</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study disease</TAG>
        <VALUE>Adenocarcinoma</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>body site</TAG>
        <VALUE>Liver</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>histological type</TAG>
        <VALUE>Tissue : Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>analyte type</TAG>
        <VALUE>RNA</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>is tumor</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>subject is affected</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_code</TAG>
        <VALUE>1</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_short_name</TAG>
        <VALUE>HMB-PUB</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="WCM161_1_N_RNA_Tumor" accession="SRS4330286">
    <IDENTIFIERS>
      <PRIMARY_ID>SRS4330286</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMN10254537</EXTERNAL_ID>
      <EXTERNAL_ID namespace="dbGaP" label="Sample name">1666-WCM161_1_N_RNA_Tumor</EXTERNAL_ID>
      <EXTERNAL_ID namespace="phs001666" label="submitted sample id">WCM161_1_N_RNA_Tumor</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Adenocarcinoma tumor RNA sample from Lymph node of a human male participant in the dbGaP study "Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer"</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_accession</TAG>
        <VALUE>phs001666</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitter handle</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study name</TAG>
        <VALUE>Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study design</TAG>
        <VALUE>Case Set</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository sample id</TAG>
        <VALUE>WCM161_1_N_RNA_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted sample id</TAG>
        <VALUE>WCM161_1_N_RNA_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted subject id</TAG>
        <VALUE>WCM161</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_sample_id</TAG>
        <VALUE>3312222</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_subject_id</TAG>
        <VALUE>2765725</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study disease</TAG>
        <VALUE>Adenocarcinoma</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>body site</TAG>
        <VALUE>Lymph node</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>histological type</TAG>
        <VALUE>Tissue : Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>analyte type</TAG>
        <VALUE>RNA</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>is tumor</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>subject is affected</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_code</TAG>
        <VALUE>1</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_short_name</TAG>
        <VALUE>HMB-PUB</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="WCM192_1_N_RNA_Tumor" accession="SRS4330287">
    <IDENTIFIERS>
      <PRIMARY_ID>SRS4330287</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMN10254555</EXTERNAL_ID>
      <EXTERNAL_ID namespace="dbGaP" label="Sample name">1666-WCM192_1_N_RNA_Tumor</EXTERNAL_ID>
      <EXTERNAL_ID namespace="phs001666" label="submitted sample id">WCM192_1_N_RNA_Tumor</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Adenocarcinoma tumor RNA sample from Prostate of a human male participant in the dbGaP study "Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer"</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_accession</TAG>
        <VALUE>phs001666</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitter handle</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study name</TAG>
        <VALUE>Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study design</TAG>
        <VALUE>Case Set</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository sample id</TAG>
        <VALUE>WCM192_1_N_RNA_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted sample id</TAG>
        <VALUE>WCM192_1_N_RNA_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted subject id</TAG>
        <VALUE>WCM192</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_sample_id</TAG>
        <VALUE>3312224</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_subject_id</TAG>
        <VALUE>2765726</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study disease</TAG>
        <VALUE>Adenocarcinoma</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>body site</TAG>
        <VALUE>Prostate</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>histological type</TAG>
        <VALUE>Tissue : Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>analyte type</TAG>
        <VALUE>RNA</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>is tumor</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>subject is affected</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_code</TAG>
        <VALUE>1</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_short_name</TAG>
        <VALUE>HMB-PUB</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="WCM209_1_C_RNA_Tumor" accession="SRS4330288">
    <IDENTIFIERS>
      <PRIMARY_ID>SRS4330288</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMN10254550</EXTERNAL_ID>
      <EXTERNAL_ID namespace="dbGaP" label="Sample name">1666-WCM209_1_C_RNA_Tumor</EXTERNAL_ID>
      <EXTERNAL_ID namespace="phs001666" label="submitted sample id">WCM209_1_C_RNA_Tumor</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Adenocarcinoma tumor RNA sample from Retroperitoneum of a human male participant in the dbGaP study "Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer"</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_accession</TAG>
        <VALUE>phs001666</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitter handle</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study name</TAG>
        <VALUE>Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study design</TAG>
        <VALUE>Case Set</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository sample id</TAG>
        <VALUE>WCM209_1_C_RNA_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted sample id</TAG>
        <VALUE>WCM209_1_C_RNA_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted subject id</TAG>
        <VALUE>WCM209</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_sample_id</TAG>
        <VALUE>3312229</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_subject_id</TAG>
        <VALUE>2765730</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study disease</TAG>
        <VALUE>Adenocarcinoma</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>body site</TAG>
        <VALUE>Retroperitoneum</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>histological type</TAG>
        <VALUE>Tissue : Castrate Resistant Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>analyte type</TAG>
        <VALUE>RNA</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>is tumor</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>subject is affected</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_code</TAG>
        <VALUE>1</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_short_name</TAG>
        <VALUE>HMB-PUB</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="WCM210_1_N_RNA_Tumor" accession="SRS4330289">
    <IDENTIFIERS>
      <PRIMARY_ID>SRS4330289</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMN10254539</EXTERNAL_ID>
      <EXTERNAL_ID namespace="dbGaP" label="Sample name">1666-WCM210_1_N_RNA_Tumor</EXTERNAL_ID>
      <EXTERNAL_ID namespace="phs001666" label="submitted sample id">WCM210_1_N_RNA_Tumor</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Adenocarcinoma tumor RNA sample from Lymph node of a human male participant in the dbGaP study "Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer"</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_accession</TAG>
        <VALUE>phs001666</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitter handle</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study name</TAG>
        <VALUE>Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study design</TAG>
        <VALUE>Case Set</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository sample id</TAG>
        <VALUE>WCM210_1_N_RNA_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted sample id</TAG>
        <VALUE>WCM210_1_N_RNA_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted subject id</TAG>
        <VALUE>WCM210</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_sample_id</TAG>
        <VALUE>3312231</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_subject_id</TAG>
        <VALUE>2765731</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study disease</TAG>
        <VALUE>Adenocarcinoma</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>body site</TAG>
        <VALUE>Lymph node</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>histological type</TAG>
        <VALUE>Tissue : Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>analyte type</TAG>
        <VALUE>RNA</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>is tumor</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>subject is affected</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_code</TAG>
        <VALUE>1</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_short_name</TAG>
        <VALUE>HMB-PUB</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="WCM213_1_C_RNA_Tumor" accession="SRS4330290">
    <IDENTIFIERS>
      <PRIMARY_ID>SRS4330290</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMN10254580</EXTERNAL_ID>
      <EXTERNAL_ID namespace="dbGaP" label="Sample name">1666-WCM213_1_C_RNA_Tumor</EXTERNAL_ID>
      <EXTERNAL_ID namespace="phs001666" label="submitted sample id">WCM213_1_C_RNA_Tumor</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Adenocarcinoma tumor RNA sample from Liver of a human male participant in the dbGaP study "Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer"</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_accession</TAG>
        <VALUE>phs001666</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitter handle</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study name</TAG>
        <VALUE>Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study design</TAG>
        <VALUE>Case Set</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository sample id</TAG>
        <VALUE>WCM213_1_C_RNA_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted sample id</TAG>
        <VALUE>WCM213_1_C_RNA_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted subject id</TAG>
        <VALUE>WCM213</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_sample_id</TAG>
        <VALUE>3312233</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_subject_id</TAG>
        <VALUE>2765732</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study disease</TAG>
        <VALUE>Adenocarcinoma</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>body site</TAG>
        <VALUE>Liver</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>histological type</TAG>
        <VALUE>Tissue : Castrate Resistant Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>analyte type</TAG>
        <VALUE>RNA</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>is tumor</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>subject is affected</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_code</TAG>
        <VALUE>1</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_short_name</TAG>
        <VALUE>HMB-PUB</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="WCM252_1_N_RNA_Tumor" accession="SRS4330291">
    <IDENTIFIERS>
      <PRIMARY_ID>SRS4330291</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMN10254584</EXTERNAL_ID>
      <EXTERNAL_ID namespace="dbGaP" label="Sample name">1666-WCM252_1_N_RNA_Tumor</EXTERNAL_ID>
      <EXTERNAL_ID namespace="phs001666" label="submitted sample id">WCM252_1_N_RNA_Tumor</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Adenocarcinoma tumor RNA sample from Liver of a human male participant in the dbGaP study "Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer"</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_accession</TAG>
        <VALUE>phs001666</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitter handle</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study name</TAG>
        <VALUE>Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study design</TAG>
        <VALUE>Case Set</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository sample id</TAG>
        <VALUE>WCM252_1_N_RNA_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted sample id</TAG>
        <VALUE>WCM252_1_N_RNA_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted subject id</TAG>
        <VALUE>WCM252</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_sample_id</TAG>
        <VALUE>3312236</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_subject_id</TAG>
        <VALUE>2765734</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study disease</TAG>
        <VALUE>Adenocarcinoma</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>body site</TAG>
        <VALUE>Liver</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>histological type</TAG>
        <VALUE>Tissue : Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>analyte type</TAG>
        <VALUE>RNA</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>is tumor</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>subject is affected</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_code</TAG>
        <VALUE>1</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_short_name</TAG>
        <VALUE>HMB-PUB</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="WCM341_1_C_RNA_Tumor" accession="SRS4330709">
    <IDENTIFIERS>
      <PRIMARY_ID>SRS4330709</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMN10254565</EXTERNAL_ID>
      <EXTERNAL_ID namespace="dbGaP" label="Sample name">1666-WCM341_1_C_RNA_Tumor</EXTERNAL_ID>
      <EXTERNAL_ID namespace="phs001666" label="submitted sample id">WCM341_1_C_RNA_Tumor</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Adenocarcinoma tumor RNA sample from Lymph node of a human male participant in the dbGaP study "Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer"</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_accession</TAG>
        <VALUE>phs001666</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitter handle</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study name</TAG>
        <VALUE>Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study design</TAG>
        <VALUE>Case Set</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository sample id</TAG>
        <VALUE>WCM341_1_C_RNA_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted sample id</TAG>
        <VALUE>WCM341_1_C_RNA_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted subject id</TAG>
        <VALUE>WCM341</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_sample_id</TAG>
        <VALUE>3312240</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_subject_id</TAG>
        <VALUE>2765737</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study disease</TAG>
        <VALUE>Adenocarcinoma</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>body site</TAG>
        <VALUE>Lymph node</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>histological type</TAG>
        <VALUE>Tissue : Castrate Resistant Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>analyte type</TAG>
        <VALUE>RNA</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>is tumor</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>subject is affected</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_code</TAG>
        <VALUE>1</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_short_name</TAG>
        <VALUE>HMB-PUB</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="WCM78_1_C_WES_Tumor" accession="SRS4330710">
    <IDENTIFIERS>
      <PRIMARY_ID>SRS4330710</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMN10254541</EXTERNAL_ID>
      <EXTERNAL_ID namespace="dbGaP" label="Sample name">1666-WCM78_1_C_WES_Tumor</EXTERNAL_ID>
      <EXTERNAL_ID namespace="phs001666" label="submitted sample id">WCM78_1_C_WES_Tumor</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Adenocarcinoma tumor DNA sample from Lymph node of a human male participant in the dbGaP study "Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer"</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_accession</TAG>
        <VALUE>phs001666</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitter handle</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study name</TAG>
        <VALUE>Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study design</TAG>
        <VALUE>Case Set</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository sample id</TAG>
        <VALUE>WCM78_1_C_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted sample id</TAG>
        <VALUE>WCM78_1_C_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted subject id</TAG>
        <VALUE>WCM78</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_sample_id</TAG>
        <VALUE>3312278</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_subject_id</TAG>
        <VALUE>2765767</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study disease</TAG>
        <VALUE>Adenocarcinoma</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>body site</TAG>
        <VALUE>Lymph node</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>histological type</TAG>
        <VALUE>Tissue : Castrate Resistant Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>analyte type</TAG>
        <VALUE>DNA</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>is tumor</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>subject is affected</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_code</TAG>
        <VALUE>1</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_short_name</TAG>
        <VALUE>HMB-PUB</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="WCM373_1_C_RNA_Tumor" accession="SRS4330711">
    <IDENTIFIERS>
      <PRIMARY_ID>SRS4330711</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMN10254534</EXTERNAL_ID>
      <EXTERNAL_ID namespace="dbGaP" label="Sample name">1666-WCM373_1_C_RNA_Tumor</EXTERNAL_ID>
      <EXTERNAL_ID namespace="phs001666" label="submitted sample id">WCM373_1_C_RNA_Tumor</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Adenocarcinoma tumor RNA sample from Liver of a human male participant in the dbGaP study "Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer"</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_accession</TAG>
        <VALUE>phs001666</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitter handle</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study name</TAG>
        <VALUE>Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study design</TAG>
        <VALUE>Case Set</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository sample id</TAG>
        <VALUE>WCM373_1_C_RNA_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted sample id</TAG>
        <VALUE>WCM373_1_C_RNA_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted subject id</TAG>
        <VALUE>WCM373</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_sample_id</TAG>
        <VALUE>3312244</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_subject_id</TAG>
        <VALUE>2765740</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study disease</TAG>
        <VALUE>Adenocarcinoma</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>body site</TAG>
        <VALUE>Liver</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>histological type</TAG>
        <VALUE>Tissue : Castrate Resistant Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>analyte type</TAG>
        <VALUE>RNA</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>is tumor</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>subject is affected</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_code</TAG>
        <VALUE>1</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_short_name</TAG>
        <VALUE>HMB-PUB</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="WCM423_1_C_RNA_Tumor" accession="SRS4330712">
    <IDENTIFIERS>
      <PRIMARY_ID>SRS4330712</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMN10254576</EXTERNAL_ID>
      <EXTERNAL_ID namespace="dbGaP" label="Sample name">1666-WCM423_1_C_RNA_Tumor</EXTERNAL_ID>
      <EXTERNAL_ID namespace="phs001666" label="submitted sample id">WCM423_1_C_RNA_Tumor</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Adenocarcinoma tumor RNA sample from Liver of a human male participant in the dbGaP study "Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer"</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_accession</TAG>
        <VALUE>phs001666</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitter handle</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study name</TAG>
        <VALUE>Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study design</TAG>
        <VALUE>Case Set</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository sample id</TAG>
        <VALUE>WCM423_1_C_RNA_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted sample id</TAG>
        <VALUE>WCM423_1_C_RNA_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted subject id</TAG>
        <VALUE>WCM423</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_sample_id</TAG>
        <VALUE>3312247</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_subject_id</TAG>
        <VALUE>2765742</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study disease</TAG>
        <VALUE>Adenocarcinoma</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>body site</TAG>
        <VALUE>Liver</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>histological type</TAG>
        <VALUE>Tissue : Castrate Resistant Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>analyte type</TAG>
        <VALUE>RNA</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>is tumor</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>subject is affected</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_code</TAG>
        <VALUE>1</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_short_name</TAG>
        <VALUE>HMB-PUB</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="WCM556_1_C_RNA_Tumor" accession="SRS4330713">
    <IDENTIFIERS>
      <PRIMARY_ID>SRS4330713</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMN10254561</EXTERNAL_ID>
      <EXTERNAL_ID namespace="dbGaP" label="Sample name">1666-WCM556_1_C_RNA_Tumor</EXTERNAL_ID>
      <EXTERNAL_ID namespace="phs001666" label="submitted sample id">WCM556_1_C_RNA_Tumor</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Adenocarcinoma tumor RNA sample from Liver of a human male participant in the dbGaP study "Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer"</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_accession</TAG>
        <VALUE>phs001666</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitter handle</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study name</TAG>
        <VALUE>Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study design</TAG>
        <VALUE>Case Set</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository sample id</TAG>
        <VALUE>WCM556_1_C_RNA_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted sample id</TAG>
        <VALUE>WCM556_1_C_RNA_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted subject id</TAG>
        <VALUE>WCM556</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_sample_id</TAG>
        <VALUE>3312252</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_subject_id</TAG>
        <VALUE>2765746</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study disease</TAG>
        <VALUE>Adenocarcinoma</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>body site</TAG>
        <VALUE>Liver</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>histological type</TAG>
        <VALUE>Tissue : Castrate Resistant Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>analyte type</TAG>
        <VALUE>RNA</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>is tumor</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>subject is affected</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_code</TAG>
        <VALUE>1</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_short_name</TAG>
        <VALUE>HMB-PUB</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="WCM573_1_N_RNA_Tumor" accession="SRS4330714">
    <IDENTIFIERS>
      <PRIMARY_ID>SRS4330714</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMN10254564</EXTERNAL_ID>
      <EXTERNAL_ID namespace="dbGaP" label="Sample name">1666-WCM573_1_N_RNA_Tumor</EXTERNAL_ID>
      <EXTERNAL_ID namespace="phs001666" label="submitted sample id">WCM573_1_N_RNA_Tumor</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Adenocarcinoma tumor RNA sample from Soft tissue of a human male participant in the dbGaP study "Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer"</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_accession</TAG>
        <VALUE>phs001666</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitter handle</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study name</TAG>
        <VALUE>Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study design</TAG>
        <VALUE>Case Set</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository sample id</TAG>
        <VALUE>WCM573_1_N_RNA_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted sample id</TAG>
        <VALUE>WCM573_1_N_RNA_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted subject id</TAG>
        <VALUE>WCM573</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_sample_id</TAG>
        <VALUE>3312255</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_subject_id</TAG>
        <VALUE>2765748</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study disease</TAG>
        <VALUE>Adenocarcinoma</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>body site</TAG>
        <VALUE>Soft tissue</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>histological type</TAG>
        <VALUE>Tissue : Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>analyte type</TAG>
        <VALUE>RNA</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>is tumor</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>subject is affected</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_code</TAG>
        <VALUE>1</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_short_name</TAG>
        <VALUE>HMB-PUB</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="WCM665_1_N_RNA_Tumor" accession="SRS4330715">
    <IDENTIFIERS>
      <PRIMARY_ID>SRS4330715</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMN10254588</EXTERNAL_ID>
      <EXTERNAL_ID namespace="dbGaP" label="Sample name">1666-WCM665_1_N_RNA_Tumor</EXTERNAL_ID>
      <EXTERNAL_ID namespace="phs001666" label="submitted sample id">WCM665_1_N_RNA_Tumor</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Adenocarcinoma tumor RNA sample from Liver of a human male participant in the dbGaP study "Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer"</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_accession</TAG>
        <VALUE>phs001666</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitter handle</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study name</TAG>
        <VALUE>Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study design</TAG>
        <VALUE>Case Set</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository sample id</TAG>
        <VALUE>WCM665_1_N_RNA_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted sample id</TAG>
        <VALUE>WCM665_1_N_RNA_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted subject id</TAG>
        <VALUE>WCM665</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_sample_id</TAG>
        <VALUE>3312269</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_subject_id</TAG>
        <VALUE>2765762</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study disease</TAG>
        <VALUE>Adenocarcinoma</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>body site</TAG>
        <VALUE>Liver</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>histological type</TAG>
        <VALUE>Tissue : Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>analyte type</TAG>
        <VALUE>RNA</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>is tumor</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>subject is affected</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_code</TAG>
        <VALUE>1</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_short_name</TAG>
        <VALUE>HMB-PUB</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="WCM666_1_N_RNA_Tumor" accession="SRS4330716">
    <IDENTIFIERS>
      <PRIMARY_ID>SRS4330716</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMN10254585</EXTERNAL_ID>
      <EXTERNAL_ID namespace="dbGaP" label="Sample name">1666-WCM666_1_N_RNA_Tumor</EXTERNAL_ID>
      <EXTERNAL_ID namespace="phs001666" label="submitted sample id">WCM666_1_N_RNA_Tumor</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Adenocarcinoma tumor RNA sample from Lymph node of a human male participant in the dbGaP study "Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer"</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_accession</TAG>
        <VALUE>phs001666</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitter handle</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study name</TAG>
        <VALUE>Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study design</TAG>
        <VALUE>Case Set</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository sample id</TAG>
        <VALUE>WCM666_1_N_RNA_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted sample id</TAG>
        <VALUE>WCM666_1_N_RNA_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted subject id</TAG>
        <VALUE>WCM666</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_sample_id</TAG>
        <VALUE>3312271</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_subject_id</TAG>
        <VALUE>2765763</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study disease</TAG>
        <VALUE>Adenocarcinoma</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>body site</TAG>
        <VALUE>Lymph node</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>histological type</TAG>
        <VALUE>Tissue : Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>analyte type</TAG>
        <VALUE>RNA</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>is tumor</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>subject is affected</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_code</TAG>
        <VALUE>1</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_short_name</TAG>
        <VALUE>HMB-PUB</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="WCM733_1_C_RNA_Tumor" accession="SRS4330717">
    <IDENTIFIERS>
      <PRIMARY_ID>SRS4330717</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMN10254536</EXTERNAL_ID>
      <EXTERNAL_ID namespace="dbGaP" label="Sample name">1666-WCM733_1_C_RNA_Tumor</EXTERNAL_ID>
      <EXTERNAL_ID namespace="phs001666" label="submitted sample id">WCM733_1_C_RNA_Tumor</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Adenocarcinoma tumor RNA sample from Liver of a human male participant in the dbGaP study "Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer"</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_accession</TAG>
        <VALUE>phs001666</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitter handle</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study name</TAG>
        <VALUE>Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study design</TAG>
        <VALUE>Case Set</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository sample id</TAG>
        <VALUE>WCM733_1_C_RNA_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted sample id</TAG>
        <VALUE>WCM733_1_C_RNA_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted subject id</TAG>
        <VALUE>WCM733</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_sample_id</TAG>
        <VALUE>3312276</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_subject_id</TAG>
        <VALUE>2765766</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study disease</TAG>
        <VALUE>Adenocarcinoma</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>body site</TAG>
        <VALUE>Liver</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>histological type</TAG>
        <VALUE>Tissue : Castrate Resistant Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>analyte type</TAG>
        <VALUE>RNA</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>is tumor</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>subject is affected</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_code</TAG>
        <VALUE>1</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_short_name</TAG>
        <VALUE>HMB-PUB</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="WCM665_1_N_WES_Tumor" accession="SRS4330862">
    <IDENTIFIERS>
      <PRIMARY_ID>SRS4330862</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMN10254538</EXTERNAL_ID>
      <EXTERNAL_ID namespace="dbGaP" label="Sample name">1666-WCM665_1_N_WES_Tumor</EXTERNAL_ID>
      <EXTERNAL_ID namespace="phs001666" label="submitted sample id">WCM665_1_N_WES_Tumor</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Adenocarcinoma tumor DNA sample from Liver of a human male participant in the dbGaP study "Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer"</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_accession</TAG>
        <VALUE>phs001666</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitter handle</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study name</TAG>
        <VALUE>Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study design</TAG>
        <VALUE>Case Set</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository sample id</TAG>
        <VALUE>WCM665_1_N_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted sample id</TAG>
        <VALUE>WCM665_1_N_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted subject id</TAG>
        <VALUE>WCM665</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_sample_id</TAG>
        <VALUE>3312270</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_subject_id</TAG>
        <VALUE>2765762</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study disease</TAG>
        <VALUE>Adenocarcinoma</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>body site</TAG>
        <VALUE>Liver</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>histological type</TAG>
        <VALUE>Tissue : Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>analyte type</TAG>
        <VALUE>DNA</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>is tumor</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>subject is affected</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_code</TAG>
        <VALUE>1</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_short_name</TAG>
        <VALUE>HMB-PUB</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="WCM666_1_N_WES_Tumor" accession="SRS4330863">
    <IDENTIFIERS>
      <PRIMARY_ID>SRS4330863</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMN10254529</EXTERNAL_ID>
      <EXTERNAL_ID namespace="dbGaP" label="Sample name">1666-WCM666_1_N_WES_Tumor</EXTERNAL_ID>
      <EXTERNAL_ID namespace="phs001666" label="submitted sample id">WCM666_1_N_WES_Tumor</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Adenocarcinoma tumor DNA sample from Lymph node of a human male participant in the dbGaP study "Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer"</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_accession</TAG>
        <VALUE>phs001666</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitter handle</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study name</TAG>
        <VALUE>Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study design</TAG>
        <VALUE>Case Set</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository sample id</TAG>
        <VALUE>WCM666_1_N_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted sample id</TAG>
        <VALUE>WCM666_1_N_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted subject id</TAG>
        <VALUE>WCM666</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_sample_id</TAG>
        <VALUE>3312272</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_subject_id</TAG>
        <VALUE>2765763</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study disease</TAG>
        <VALUE>Adenocarcinoma</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>body site</TAG>
        <VALUE>Lymph node</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>histological type</TAG>
        <VALUE>Tissue : Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>analyte type</TAG>
        <VALUE>DNA</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>is tumor</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>subject is affected</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_code</TAG>
        <VALUE>1</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_short_name</TAG>
        <VALUE>HMB-PUB</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="WCM668_1_C_WES_Tumor" accession="SRS4330864">
    <IDENTIFIERS>
      <PRIMARY_ID>SRS4330864</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMN10254587</EXTERNAL_ID>
      <EXTERNAL_ID namespace="dbGaP" label="Sample name">1666-WCM668_1_C_WES_Tumor</EXTERNAL_ID>
      <EXTERNAL_ID namespace="phs001666" label="submitted sample id">WCM668_1_C_WES_Tumor</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Adenocarcinoma tumor DNA sample from Right posterior iliac bone of a human male participant in the dbGaP study "Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer"</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_accession</TAG>
        <VALUE>phs001666</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitter handle</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study name</TAG>
        <VALUE>Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study design</TAG>
        <VALUE>Case Set</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository sample id</TAG>
        <VALUE>WCM668_1_C_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted sample id</TAG>
        <VALUE>WCM668_1_C_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted subject id</TAG>
        <VALUE>WCM668</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_sample_id</TAG>
        <VALUE>3312273</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_subject_id</TAG>
        <VALUE>2765764</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study disease</TAG>
        <VALUE>Adenocarcinoma</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>body site</TAG>
        <VALUE>Right posterior iliac bone</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>histological type</TAG>
        <VALUE>Tissue : Castrate Resistant Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>analyte type</TAG>
        <VALUE>DNA</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>is tumor</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>subject is affected</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_code</TAG>
        <VALUE>1</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_short_name</TAG>
        <VALUE>HMB-PUB</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="WCM688_1_N_WES_Tumor" accession="SRS4330865">
    <IDENTIFIERS>
      <PRIMARY_ID>SRS4330865</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMN10254577</EXTERNAL_ID>
      <EXTERNAL_ID namespace="dbGaP" label="Sample name">1666-WCM688_1_N_WES_Tumor</EXTERNAL_ID>
      <EXTERNAL_ID namespace="phs001666" label="submitted sample id">WCM688_1_N_WES_Tumor</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Adenocarcinoma tumor DNA sample from Lymph node of a human male participant in the dbGaP study "Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer"</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_accession</TAG>
        <VALUE>phs001666</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitter handle</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study name</TAG>
        <VALUE>Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study design</TAG>
        <VALUE>Case Set</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository sample id</TAG>
        <VALUE>WCM688_1_N_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted sample id</TAG>
        <VALUE>WCM688_1_N_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted subject id</TAG>
        <VALUE>WCM688</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_sample_id</TAG>
        <VALUE>3312274</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_subject_id</TAG>
        <VALUE>2765765</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study disease</TAG>
        <VALUE>Adenocarcinoma</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>body site</TAG>
        <VALUE>Lymph node</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>histological type</TAG>
        <VALUE>Tissue : Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>analyte type</TAG>
        <VALUE>DNA</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>is tumor</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>subject is affected</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_code</TAG>
        <VALUE>1</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_short_name</TAG>
        <VALUE>HMB-PUB</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="WCM733_1_C_WES_Tumor" accession="SRS4330866">
    <IDENTIFIERS>
      <PRIMARY_ID>SRS4330866</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMN10254549</EXTERNAL_ID>
      <EXTERNAL_ID namespace="dbGaP" label="Sample name">1666-WCM733_1_C_WES_Tumor</EXTERNAL_ID>
      <EXTERNAL_ID namespace="phs001666" label="submitted sample id">WCM733_1_C_WES_Tumor</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Adenocarcinoma tumor DNA sample from Liver of a human male participant in the dbGaP study "Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer"</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_accession</TAG>
        <VALUE>phs001666</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitter handle</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository</TAG>
        <VALUE>NCI_Alisertib_PC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study name</TAG>
        <VALUE>Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study design</TAG>
        <VALUE>Case Set</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biospecimen repository sample id</TAG>
        <VALUE>WCM733_1_C_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted sample id</TAG>
        <VALUE>WCM733_1_C_WES_Tumor</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>submitted subject id</TAG>
        <VALUE>WCM733</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_sample_id</TAG>
        <VALUE>3312277</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_subject_id</TAG>
        <VALUE>2765766</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>male</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>study disease</TAG>
        <VALUE>Adenocarcinoma</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>body site</TAG>
        <VALUE>Liver</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>histological type</TAG>
        <VALUE>Tissue : Castrate Resistant Prostate Cancer</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>analyte type</TAG>
        <VALUE>DNA</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>is tumor</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>subject is affected</TAG>
        <VALUE>Yes</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_code</TAG>
        <VALUE>1</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>gap_consent_short_name</TAG>
        <VALUE>HMB-PUB</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
</SAMPLE_SET>
